RT Journal Article
SR Electronic
T1 Does frequency or diversity of leisure activity matter more for epigenetic ageing? Analyses of arts engagement and physical activity in the UK Household Longitudinal Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.11.01.24316559
DO 10.1101/2024.11.01.24316559
A1 Fancourt, Daisy
A1 Masebo, Lehané
A1 Finn, Saoirse
A1 Mak, Hei Wan
A1 Bu, Feifei
YR 2024
UL http://medrxiv.org/content/early/2024/11/02/2024.11.01.24316559.abstract
AB Over the past decade, ageing clocks have become widely adopted as important tools for understanding biological ageing and have been redefining notions of “pro-longevity” lifestyles. However, this work is still at an early stage. Some leisure activities, such as arts and cultural engagement (ACEng) have never been studied at all, while others such as physical activity (PA) have only received scant attention. In particular, there is little understanding of whether frequency of engagement or diversity (which provides access to more active ingredients) is more important. This study used 3,354 adults in the UK Household Longitudinal Study - a large, nationally-representative cohort study, which includes six derived epigenetic clocks. We used a doubly robust estimation using the inverse-probability-weighted regression adjustment estimator adjusted for demographic, socioeconomic, behavioural and health covariates, data collection gaps and technical covariates of epigenetic clocks. ACEng and PA were related to slower biological ageing in the PhenoAge and DunedinPoAm clocks, although not to the other measured clocks, with comparable effect sizes between ACEng and PA (Lin, Horvath2018, Horvath2013 and Hannum). For ACEng, diversity and frequency of engagement were related to DunedinPoAm, while for PhenoAge, there was a slightly clearer relationship for frequency than diversity. For PA, higher levels of frequency, diversity, and activeness were related to DunedinPoAm, while only the highest diversity and activeness were related to PhenoAge. These findings were all stronger amongst middle-aged and older adults. This was the first study to show a relationship between ACEng and epigenetic ageing, with comparable effect sizes to PA, suggesting the value of its exploration alongside other lifestyle factors. Decelerations in ageing clocks, including those within our study, have been demonstrated to have clinical (as well as statistical) importance, supporting future exploration as to whether lifestyle changes have any value to slowing or potentially reversing epigenetic ageing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis paper is supported by the UK Research and Innovation [MR/Y01068X/1]. LM was supported by a PhD studentship provided through the Soc-B Centre for Doctoral Training (CDT), funded by the Economic and Social Research Council (ESRC) and the Biotechnology & Biological Sciences Research Council (BBSRC)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data were openly available prior to analyses commencing. Data can be accessed through https://www.understandingsociety.ac.uk/ and https://beta.ukdataservice.ac.uk/datacatalogue/series/series?id=2000053I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesData are publicly available through UKDS https://beta.ukdataservice.ac.uk/datacatalogue/series/series?id=2000053